Clinical Trial Update: Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery [NA]

View source ↗

Summary

A clinical trial evaluating inotropic treatment with levosimendan (Simdax) in heart surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Simdax (levosimendan)

Snippet

Sponsor: Ullevaal University Hospital | Conditions: Heart Failure, Cardiac Surgery | NA | Status: TERMINATED